| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Antigenic Specificity | PD-1 |
|---|
| Clone | monoclonal |
|---|
| Host Species | Human |
|---|
| Reactive Species | human |
|---|
| Isotype | IgG4 |
|---|
| Format | affinity purified |
|---|
| Size | 100 μg |
|---|
| Concentration | n/a |
|---|
| Applications | Neutralization, ELISA |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | Monoclonal human IgG1 antibody against human PD-1. Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells. |
|---|
| Immunogen | Human programmed cell death 1 receptor (PD1) |
|---|
| Other Names | Keytruda, PD-1 |
|---|
| Gene, Accession # | Gene ID: 18566, Accession: Q02242 |
|---|
| Catalog # | A1306-100 |
|---|
| Price | |
|---|
| Order / More Info | PD-1 Antibody from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|